Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss the implications of a child’s tragic death after receiving a brain-focused gene therapy, hear Siddhartha …

… a startup with a gout drug candidate in Phase 3 development … it ineffective. Sobi’s gout drug candidate is also an … , to this Selecta Biosciences gout drug candidate. In Phase 3 … efficacy advantages over currently available gout medications. Two Phase 3 tests …

… an oral first-in-class gout drug candidate that selectively inhibits hURAT1 …

New findings that a common treatment for gout also cuts heart attacks adds weight to the idea that the 'plumbing' theory of heart disease isn't the whole picture This is Everyday Science with Clare Wilson, a subscriber-only newsletter from The …

A widely available drug used for gout may help prevent heart attacks and stroke in people with cardiovascular disease. The corresponding review was published in the Cochrane Database of Systematic Reviews.  "Among 200 people with cardiovascular …

Colchicine is a medication typically used to help treat gout, mainly by treating pain and inflammation. A recent review found that low dose colchicine may help prevent heart attacks and strokes in individuals who already have cardiovascular disease. The …

In recent years, scientists have increasingly turned their attention to older, affordable drugs to explore whether they offer benefits beyond their original purpose. Colchicine, a cheap and widely used medication for gout, has emerged as a strong candidate …

A cheap gout drug, colchicine, may significantly reduce heart … Collaboration’s journal. Long-Used Gout Drug Shows New Promise for Heart … early evidence suggests this humble gout drug could soon play a much …

A widely-used, inexpensive gout drug could reduce heart attacks and …

A commonly used, low-cost medication for gout may help lower the chances of heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review. Researchers evaluated the impact of taking small doses of colchicine, a …